IC4 Flashcards
Common clinical indications for macrolides
atypical microbes
Common clinical indications for macrolides
atypical microbes, respiratory tract infections (CAP), Chlamydial infections, Diphtheria, H.pylori (Clarithromycin/Azithromycin + omeprazole +amoxicillin), Mycobacterial infections
Which macrolides is usually destroyed by gastric acid and thus administered in either enteric-coated tablets or esterified forms?
Erythromycin
ROA for macrolides
IV and Oral except clarithromycin (Oral only)
Adverse effects of macrolides
- Gastric distress and motility (Less with clarithromycin and azithromycin than erythromycin (motilin agonist))
- Hepatotoxicity: Cholestatic jaundice
- Ototoxicity
- may prolong the QT interval and should be used with caution in those patients with pro-arrhythmic conditions
which other drug can antagonise action of clindamycin?
Although clindamycin and erythromycin are not structurally related, they act at sites of proximity, and can antagonise each others action.
Cross resistance with macrolides due to (erm) methylases can also occur
what is clindamycin useful against?
anaerobic infection
dosage form for clindamycin
Oral and IV; topical solution, gel, or lotion and vaginal cream
Contraindication for clindamycin
CDAD, pseudomembranous colitis / ulcerative colitis
MOA of Resistance in clindamycin
- Alteration of the 50S ribosomal subunit by aa substitution
- Alteration in the 23S ribosomal RNA subunit by methylation and nucleotidylation of the hydroxyl group of clindamycin.
Activity of linezolid
Gram positive only (incl MRSA, VRE, VRSA)
MOA of linezolid
Binds the bacterial 23S ribosomal RNA of the 50S subunit and prevents the formation of a functional 70S initiation complex, which is an essential component of the bacterial translation process.
Dosage form for linezolid
Oral and IV
MOA of Resistance to linezolid
- Mutations in the 23S ribosomal RNA is the major cause of linezolid resistance in VRE and MRSA.
- Resistance can also be conferred by the cfr rRNA methyltransferase against lincosamides and oxazolidinones
Adverse effects of linezolid
- GI effects
- Bone Marrow Suppression: Thrombocytopenia has been reported in patients taking the drug for >10 days. (Need to monitor blood counts)
- may lead to serotonin syndrome if given concomitantly with selective serotonin reuptake inhibitors, or MAO inhibitors (reversible)
- Irreversible peripheral neuropathies and optic neuritis (causing blindness) have been associated with > 28 days of use
Contraindication for linezolid
- Treatment of catheter-related bloodstream infections or catheter-site infections
- Do not use within two weeks of MAO inhibitors, e.g., phenelzine
- Tyramine-containing foods and serotonergic drugs, as these may precipitate a hypertensive crisis.
Examples of tyramine-containing foods include aged cheese, cured or smoked meats, draft beer, fava beans, and soy products.
MOA for fluoroquinolones
- targets DNA gyrase, primarily in Gram-negative bacteria
- targets topoisomerase IV in Gram-positive bacteria
to inhibit DNA replication
Clearance method for various fluoroquinolones
Levofloxacin/ Ciprofloxain: Renal CL
Moxifloxacin: Hepatic CL
Generation for various fluoroquinolones
2nd: Ciprofloxacin
3rd: Levofloxacin, Moxifloxacin
3rd gen fluoroquinolones vs 2nd gen advantage
- Better coverage against Gram positive organisms, especially S. pneumoniae
- Increased coverage against atypical pathogens such as Mycoplasma pneumoniae and Chlamydia pneumoniae
Hence 3rd gen known as respiratory quinolones
Adverse effects of fluoroquinolones
- GI related (most common) - nausea, vomiting, and diarrhoea
- Risk of dysglycaemia especially in diabetic patients
- Aortic dissections or ruptures of an aortic aneurysm - rare
- Increased risk of C. diff colitis as they clear the bowel flora, esp with
ciprofloxacin - Headache and dizziness or light headedness may occur. Thus, patients with CNS disorders, such as epilepsy, should be treated cautiously with these drugs.
- phototoxicity
- An increased risk of tendinitis or tendon rupture may occur with systemic fluoroquinolone use.
- may prolong the QTc interval (more common with third gen)
- Peripheral Neuropathy with systemic use
Contraindication for fluoroquinolones
- Not recommended for infants or children < 18 years of age as they have been shown to cause joint problems (arthropathy) in young animals.
- Ciprofloxacin in lactation
- Patients with myasthenia gravis because it may exacerbate muscle weaknesses.
- G6PD deficiency
Quinolones may also raise the serum levels of warfarin, and cyclosporine.